Home › NDC Lookup › RxCUI directory › RxCUI 1440007

Cod liver oil 0.1 MG/MG / petrolatum 0.3 MG/MG Topical Ointment — RxCUI 1440007

RxNorm drug concept · Semantic clinical drug
RxCUI 1440007 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1440007
Official nameCod liver oil 0.1 MG/MG / petrolatum 0.3 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascod liver oil 10 % / petrolatum 30 % Topical Ointment
FDA products mapped6
Package NDCs mapped17
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Cod liver oil 0.1 MG/MG / petrolatum 0.3 MG/MG T... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cod liver oil 0.1 MG/MG / petrolatum 0.3 MG/MG Topical Ointment RxCUI 1440007

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Cod liver oil 2669
    • Petrolatum 8091
    • Cod liver oil / petrolatum 1440006
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cod liver oil / petrolatum Topical Ointment 1440005
    • Cod liver oil / petrolatum Topical Product 1440004
    • Topical Ointment 316985
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cod liver oil 0.1 MG/MG 438574
    • Petrolatum 0.3 MG/MG 1037283

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cod liver oil 0.1 MG/MG SCDC · 438574
  • Petrolatum 0.3 MG/MG SCDC · 1037283
  • Cod liver oil / petrolatum Topical Ointment SCDF · 1440005
  • Cod liver oil / petrolatum Topical Product SCDG · 1440004

📦 FDA Products & Package NDCs

6 products · 17 package NDCs
17 package NDCs map to RxCUI 1440007 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65121-0712-64 120 mL in 1 JAR (65121-712-64) Curefini Pure Source, LLC 2017-02-07
65121-0712-65 240 mL in 1 JAR (65121-712-65) Curefini Pure Source, LLC 2017-02-07
69981-0704-01 30 mL in 1 JAR (69981-704-01) CUREFINI Dermal Rev Pharma Corporation 2022-01-10
69981-0704-02 60 mL in 1 JAR (69981-704-02) CUREFINI Dermal Rev Pharma Corporation 2022-01-10
69981-0704-04 120 mL in 1 JAR (69981-704-04) CUREFINI Dermal Rev Pharma Corporation 2022-01-10
69981-0704-08 240 mL in 1 JAR (69981-704-08) CUREFINI Dermal Rev Pharma Corporation 2022-01-10
69981-0710-04 120 mL in 1 JAR (69981-710-04) CURACID Dermal for cuts and burns Rev Pharma Corp. 2019-05-01
69981-0712-64 120 mL in 1 JAR (69981-712-64) CUREFINI Rev Pharma Corp. 2013-01-17
69981-0712-65 240 mL in 1 JAR (69981-712-65) CUREFINI Rev Pharma Corp. 2013-01-17
69981-0754-01 120 mL in 1 JAR (69981-754-01) Curefini Dermal Rev Pharma Corp 2016-08-02
69981-0754-02 240 mL in 1 JAR (69981-754-02) Curefini Dermal Rev Pharma Corp 2016-08-02
69981-0754-03 30 mL in 1 JAR (69981-754-03) Curefini Dermal Rev Pharma Corp 2020-05-08
69981-0754-04 60 mL in 1 JAR (69981-754-04) Curefini Dermal Rev Pharma Corp 2020-05-08
79974-0202-01 30 mL in 1 JAR (79974-202-01) CUREFINI Miramar Cosmetics, Inc DBA Miramar Lab 2022-06-01
79974-0202-02 60 mL in 1 JAR (79974-202-02) CUREFINI Miramar Cosmetics, Inc DBA Miramar Lab 2022-06-01
79974-0202-04 120 mL in 1 JAR (79974-202-04) CUREFINI Miramar Cosmetics, Inc DBA Miramar Lab 2022-06-01
79974-0202-08 240 mL in 1 JAR (79974-202-08) CUREFINI Miramar Cosmetics, Inc DBA Miramar Lab 2022-06-01
Observed labelers: Miramar Cosmetics, Inc DBA Miramar Lab (4) · Rev Pharma Corp (4) · Rev Pharma Corporation (4) · Rev Pharma Corp. (3) · Pure Source, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.